Skip to main content

LPA1 inhibition induces metastatic dormancy in mouse models of breast cancer



This is really great!

A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to astudy published August 21 in the Journal of the National Cancer Institute.

Metastasis is a main contributor to mortality in cancer patients.

Patients with “triple negative” breast cancer (tumour cells that are hormone receptor negative and express normal levels of the HER2 oncogene) are known to be at high risk for metastatic progression.

In addition, breast and prostate cancers are known for having variable but possibly long periods of dormancy, where the disease is silent.

Factors inducing or breaking a dormant state are poorly understood, but extending dormancy is considered a therapeutic goal.

To determine the effects of LPA1 inhibition on metastatic dormancy, Jean-Claude A. Marshall, MSc., Ph.D. of the Women’s Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, and colleagues analyzed primary tumour size, distant metastases and their molecular characteristics in two model systems of aggressive “triple negative” breast cancer metastasis, the murine 4T1 mammary carcinoma model and human MDA-MB-231 human breast carcinoma model. Debio-0719 or shRNA knockdown of LPA1 significantly inhibited metastasis formation without affecting primary tumour size.

Tumour cells found in distant organs, such as the lungs and liver of Debio-0719 treated mice, had ceased proliferation and exhibited other molecular hallmarks of dormancy.
LPA1 inhibition represents one of the first compounds to induce dormancy in metastatic sites in triple negative breast cancer.

The authors point out that LPA1 inhibition had no effect on the growth of the primary tumors in either model system. As such, it would not normally be considered further for drug development.
Their data suggest that alternative drug development approaches may identify compounds with novel activities, such as metastatic dormancy.

The authors point out that their study did not determine the duration of tumour dormancy, and that Debio-0719 and other LPA1 inhibitors should be tested in additional model systems.

However, they conclude: “With such inhibitors in hand, the interaction of dormancy pathways and standard of care therapeutics, radiation therapy, patient stress, and other important factors can be determined to develop a deeper picture of potential preventative and therapeutic scenarios.”

Popular posts from this blog

"Hard nipples" - areola or nipple skin

Someone once wrote"...when i get really cold, or get goosebumbs all over my body, the whole things really scrunch up, like, my entire areola scrunches itself up into a wrinkled little mound. it looks really weird and ugly, and i haven't ever seen other people's breasts do it. what is wrong with my areola/nipples??" The answer: Well nothing is wrong. This is what my areola does too. It's a normal reaction to the coldness or to irritation / stimulation. The little muscles in the areola do a similar goosebump thing as your other skin can do. People often call this phenomenon "hard nipples". Also note that skin on areola has less feeling or sensation to it than other areas of your body. If the areola was very sensitive, then breastfeeding would probably be quite uncomfortable because the baby pulls and tugs it! The nipples are sensitive but the sensitivity changes with hormonal changes, such as occur at mestrual cycle or pregnancy. Also this varies with ind…

2017 gone and 2018 hello another travel year!

Here we go again a brand new year. Lots to be grateful for. This year sees a lot of interesting things happening and as we know you get out of life what you put into it.
You know when you spend time with people and they don't do fun things and they don't have much to offer a conversation.
Well that is no one that I know. (Anymore) if you get what I mean.
This year sees my favourite travel buddy of all time Ann and I heading on another adventure. Well actually it's true 3 for us.
Trip 1) Dubai, Egypt, Cyprus and Gallipoli 2005
Trip 2) Italy, Athens, Mikonos and Santorini 2011
So this year sees us off to a great part of the world again and different,
Trip 3) Amazon Jungle, Rio, Argentina and Chilli 2018 yay this year!
Ann and I have been friends since kindergarten so there is a long history nearly all our lives just about.
We have a ball on our trips we have met so many amazing people and seen some pretty amazing things. But all in all we are doing adventures seeing the worl…

Cancer - Public Speaking and Cancer Advocate

Hi one thing I have learnt in the life is to share and help others. If you can save one person from going through something bad or helping them. That's what this life is all about.
Ok what I do!
For events or Charities please contact me on the following subjects.
Inspirational public speaker!
My Battle with not one but 2 Cancer Battles Loosing my Mother to Ovarian Cancer PTSD - overcoming challenges Overcoming Change and Staying positive The Best secrets to getting through medical Mahiem Now That We Have It,  How Do We Do it All? The Modern Woman’s Way Embracing Change: The New Reality for You and your family Strategies for Success: Women’s Getting on the right track Leadership and Achieving DreamsMy Journey From Small Country town girl to Sydney Executive #publicspeaking #cancerevents #survivor #yournotalone